| 12234457 |
P-ethoxy nucleic acids for BCL2 inhibition |
Ana Tari Ashizawa |
2025-02-25 |
|
| 12097214 |
P-ethoxy nucleic acids for liposomal formulation |
— |
2024-09-24 |
$84,000 |
| 10898436 |
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions |
Barbara Freund, Jörg Heeren, Antonella Carambia, Johannes Herkel, Oliver Bruns +4 more |
2021-01-26 |
|
| 10898506 |
P-ethoxy nucleic acids for liposomal formulation |
— |
2021-01-26 |
$437,000 |
| 10335428 |
P-ethoxy nucleic acids for liposomal formulation |
— |
2019-07-02 |
$3,458,000 |
| 10004689 |
Nanoparticle compositions for generation of regulatory T cells and treatment of autoimmune diseases and other chronic inflammatory conditions |
Barbara Freund, Jörg Heeren, Antonella Carambia, Johannes Herkel, Oliver Bruns +4 more |
2018-06-26 |
|
| 9744187 |
p-Ethoxy nucleic acids for liposomal formulation |
— |
2017-08-29 |
$462,000 |
| 7825215 |
Substituted nucleic acid mimics |
Leif Christensen, Henrik Frydenlund Hansen |
2010-11-02 |
|
| 7569659 |
Admixture comprising a target molecule and a nucleic acid mimic comprising sterically bulky substituents |
Leif Christensen, Henrik Frydenlund Hansen |
2009-08-04 |
|
| 7378485 |
Peptide nucleic acids with polyamide-containing backbones |
Ole Buchardt, Michael Egholm, Rolf Henrik Berg |
2008-05-27 |
|
| 7223833 |
Peptide nucleic acid conjugates |
Ole Buchardt, Soren Holst Sonnechsen, Jesper Lohse, Michael Egholm, Muthiah Manoharan +3 more |
2007-05-29 |
$4,761,000 |
| 7043437 |
Standardized inpatient-outpatient nomenclatures and accepting both outpatient and inpatient data to commonly accessible storage |
Brook A. Thomson |
2006-05-09 |
|
| 6876780 |
Providing for automated note completion |
Brook A. Thomson |
2005-04-05 |
|
| 6770738 |
Higher order structure and binding of peptide nucleic acids |
David J. Ecker, Ole Buchardt, Michael Egholm, Rolf Henrik Berg, Niels E. Mollegaard |
2004-08-03 |
$1,717,000 |
| 6734161 |
Peptide nucleic acids having antibacterial activity |
Liam Good |
2004-05-11 |
|
| 6713602 |
Synthetic procedures for peptide nucleic acids |
Ole Buchardt, Michael Egholm, Rolf Henrik Berg |
2004-03-30 |
|
| 6710164 |
Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
Michael Egholm, Rolf Henrik Berg, Ole Buchardt |
2004-03-23 |
|
| 6710163 |
Peptide nucleic acid synthons |
Ole Buchardt, Michael Egholm, Rolf Henrik Berg |
2004-03-23 |
|
| 6632919 |
Peptide nucleic acid monomers and oligomers |
Gerald Haaima, Anne B. Eldrup |
2003-10-14 |
|
| 6617422 |
Peptide nucleic acid monomers and oligomers |
Gerald Haaima, Anne B. Eldrup |
2003-09-09 |
|
| 6613873 |
Peptide nucleic acids having 2,6-diaminopurine nucleobases |
Ole Buchardt, Michael Egholm, Rolf Henrik Berg |
2003-09-02 |
$3,039,000 |
| 6610650 |
Modulation of cellular transcription factor activity |
Benget Norden, Pernilla Wittung, Ole Buchardt, Michael Egholm, Rolf Henrik Berg |
2003-08-26 |
|
| 6548651 |
Modified peptide nucleic acid (PNA) molecules |
Liam Good, Henrik Frydenlund Hansen, Frederik Beck, Leila Malik, Carsten Schou +2 more |
2003-04-15 |
|
| 6451968 |
Peptide nucleic acids |
Michael Egholm, Ole Buchardt, Kim L. Dueholm, Leif Christensen, James M. Coull +2 more |
2002-09-17 |
$1,975,000 |
| 6441130 |
Linked peptide nucleic acids |
Michael Egholm, Ole Buchardt, Kim L. Dueholm, Leif Christensen, James M. Coull +2 more |
2002-08-27 |
$1,688,000 |